<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00749710</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-08-ES-143-CTIL</org_study_id>
    <secondary_id>non</secondary_id>
    <nct_id>NCT00749710</nct_id>
  </id_info>
  <brief_title>Blood Loss and Complications of Internal Fixation of Femoral Neck Fractures in Patients Treated With Clopidogrel</brief_title>
  <official_title>Blood Loss and Complications of Internal Fixation of Femoral Neck Fractures in Patients Treated With Clopidogrel</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients suffering from femoral neck or pertrochanteric fractures have a high rate of
      mortality and morbidity associated mainly with deconditioning and immobilization. Surgical
      management including open reduction and internaql fixation has been shown to reduce
      complication and improve outcome in such patients. Delay of surgery produces less optimal
      results and is associated with higher morbidity even after 24-48 hours of fracture event.

      Patients treated with platelet antiaggregants are exposed to higher blood loss during surgery
      and related complications, as demonstrated in patients treated with Aspirin. However,
      cessation of antiaggregant therapy before surgery may be associated with complications of a
      hypercoagulable state and surgery delay.

      Clpopidogrel is a fairly new approved antiaggregant drug indicated in cases of failed aspirin
      treatment in ischemic heart disease and cerebrovascular disease patients as well as in
      primary prevention of stent restenosis.

      No data regarding complications of hip surgery in patients treated with Clpopidogrel is
      available.

      Study hypothesis:

      Definitive surgical treatment of patients treated with clopidogrel undergoing open reduction
      and internal fixation of pertrochnteric and femoral neck fractures is safe although
      associated with more extensive blood loss during surgery and postoperative wound
      complications.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality 30 days, 1 year functional score 1 year blood loss at surgery blood transfusions during hospitalization wound complications</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Femoral Neck Fractures</condition>
  <condition>Pertrochanteric Fractures</condition>
  <condition>Antiaggregant Therapy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>immediate operation - ORIF - of hip fracture in patient treated with clopidogrel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ORIF - surgical treatment patients not on antiaggregant therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>clopidogrel</intervention_name>
    <description>ORIF - surgical treatment</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>no antiaggregant therapy</intervention_name>
    <description>ORIF - surgical treatment</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 60

          -  pertrochanteric or femoral neck fracture within 48 hours

          -  clopidogrel treatment - study group

          -  no antiaggregant treatment - control group

          -  ASA score &lt;=3

        Exclusion Criteria:

          -  hematologic malignancy

          -  hematologic malfunction

          -  warfarin treatment

          -  previous active GI or other internal bleeding - within 1 year

          -  thrombocytopenia &lt; 150
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ely Steinberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ely Steinberg, MD</last_name>
    <phone>972-52-4266346</phone>
    <email>steinberge@tasmc.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ofir chechik, MD</last_name>
    <phone>972-52-2653820</phone>
    <email>ofirchik@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep. 2003 Sep;1(2):78-85. Review.</citation>
    <PMID>16036069</PMID>
  </reference>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2008</study_first_submitted>
  <study_first_submitted_qc>September 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2008</study_first_posted>
  <last_update_submitted>September 8, 2008</last_update_submitted>
  <last_update_submitted_qc>September 8, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2008</last_update_posted>
  <responsible_party>
    <name_title>Steinberg Ely MD</name_title>
    <organization>Tel-Aviv Sourasky Medical Center</organization>
  </responsible_party>
  <keyword>femoral neck fractures</keyword>
  <keyword>pertrochanteric fractures</keyword>
  <keyword>antiaggregant therapy</keyword>
  <keyword>clopidogrel</keyword>
  <keyword>plavix</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Femoral Neck Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Ticlopidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

